Literature DB >> 15786629

Deaths: leading causes for 2002.

Robert N Anderson1, Betty L Smith.   

Abstract

OBJECTIVES: This report presents final 2002 data on the 10 leading causes of death in the United States by age, race, sex, and Hispanic origin. Leading causes of infant, neonatal, and postneonatal death are also presented. This report supplements the annual report of final mortality statistics.
METHODS: Data in this report are based on information from all death certificates filed in the 50 States and the District of Columbia in 2002. Causes of death classified by the International Classification of Diseases, Tenth Revision (ICD-10) are ranked according to the number of deaths assigned to rankable causes.
RESULTS: In 2002, the 10 leading causes of death were (in rank order) Diseases of heart; Malignant neoplasms; Cerebrovascular diseases; Chronic lower respiratory diseases; Accidents (unintentional injuries); Diabetes mellitus; Influenza and pneumonia; Alzheimer's disease; Nephritis, nephrotic syndrome and nephrosis; and Septicemia and accounted for about 79 percent of all deaths occurring in the United States. Differences in the rankings are evident by age, sex, race, and Hispanic origin. Leading causes of infant death for 2002 were (in rank order) Congenital malformations, deformations and chromosomal abnormalities; Disorders related to short gestation and low birthweight, not elsewhere classified; Sudden infant death syndrome; Newborn affected by maternal complications of pregnancy; Newborn affected by complications of placenta, cord and membranes; Accidents (unintentional injuries); Respiratory distress of newborn; Bacterial sepsis of newborn; Diseases of the circulatory system; and Intrauterine hypoxia and birth asphyxia. Important variation in the leading causes of infant death is noted for the neonatal and postneonatal periods.

Entities:  

Mesh:

Year:  2005        PMID: 15786629

Source DB:  PubMed          Journal:  Natl Vital Stat Rep        ISSN: 1551-8922


  84 in total

1.  Efficacy and safety of glucocorticoids in the treatment of community-acquired pneumonia: A meta-analysis of randomized controlled trials.

Authors:  Li-Ping Chen; Jun-Hui Chen; Ying Chen; Chao Wu; Xiao-Hong Yang
Journal:  World J Emerg Med       Date:  2015

2.  Kinase activity profiling of gram-negative pneumonia.

Authors:  Arie J Hoogendijk; Sander H Diks; Maikel P Peppelenbosch; Tom Van Der Poll; Catharina W Wieland
Journal:  Mol Med       Date:  2011-03-15       Impact factor: 6.354

Review 3.  Cardiovascular safety profiles of aromatase inhibitors : a comparative review.

Authors:  Jean-Marc Nabholtz; Joseph Gligorov
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Suicide risk factors in children and adolescents with bipolar disorder.

Authors:  Edith M Jolin; Elizabeth B Weller; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

5.  Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates.

Authors:  András Gruber; Ulla M Marzec; Leslie Bush; Enrico Di Cera; José A Fernández; Michelle A Berny; Erik I Tucker; Owen J T McCarty; John H Griffin; Stephen R Hanson
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

6.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

7.  AMP-activated protein kinase activation by 5-aminoimidazole-4-carbox-amide-1-β-D-ribofuranoside (AICAR) reduces lipoteichoic acid-induced lung inflammation.

Authors:  Arie J Hoogendijk; Sandra S Pinhanços; Tom van der Poll; Catharina W Wieland
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

8.  A longitudinal study of the prevalence, development, and persistence of HIV/sexually transmitted infection risk behaviors in delinquent youth: implications for health care in the community.

Authors:  Erin Gregory Romero; Linda A Teplin; Gary M McClelland; Karen M Abram; Leah J Welty; Jason J Washburn
Journal:  Pediatrics       Date:  2007-05       Impact factor: 7.124

9.  Assessment and treatment of stroke in children.

Authors:  Lori C Jordan
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

10.  The burden of diabetes-related mortality in France in 2002: an analysis using both underlying and multiple causes of death.

Authors:  Isabelle Romon; Eric Jougla; Beverley Balkau; Anne Fagot-Campagna
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.